---
title: "Huaren Pharmaceutical: The application for the listing of isoproterenol hydrochloride chemical raw materials has been approved"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/255568142.md"
description: "Huaren Pharmaceutical's wholly-owned subsidiary Anhui Hengxing Pharmaceutical has received approval from the National Medical Products Administration for the market launch application of isoproterenol hydrochloride chemical raw materials. This drug is a non-selective β-adrenergic agonist, primarily used to treat cardiogenic or infectious shock, atrioventricular conduction block, cardiac arrest, and acute bronchial asthma attacks"
datetime: "2025-09-02T08:19:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255568142.md)
  - [en](https://longbridge.com/en/news/255568142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255568142.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/255568142.md) | [English](https://longbridge.com/en/news/255568142.md)


# Huaren Pharmaceutical: The application for the listing of isoproterenol hydrochloride chemical raw materials has been approved

According to the Zhitong Finance APP, Huaren Pharmaceutical (300110.SZ) announced that its wholly-owned subsidiary Anhui Hengxing Pharmaceutical Co., Ltd. (referred to as "Anhui Hengxing Pharmaceutical") has received the "Approval Notice for the Listing Application of Isoproterenol Hydrochloride" issued by the National Medical Products Administration.

Isoproterenol hydrochloride is a non-selective β-adrenergic receptor agonist that strongly stimulates β1 and β2 receptors, exhibiting powerful positive inotropic, positive chronotropic, and bronchodilator effects. Clinically, it is mainly used to treat cardiogenic or infectious shock, complete atrioventricular block, cardiac arrest, and acute attacks of bronchial asthma

### 相關股票

- [Huaren Pharmaceutical (300110.CN)](https://longbridge.com/zh-HK/quote/300110.CN.md)

## 相關資訊與研究

- [Huaming Files For Hong Kong IPO, Riding Power Equipment Boom](https://longbridge.com/zh-HK/news/279427411.md)
- [Shanghai Pharmaceuticals Passes Generic Drug Evaluation for Antibiotic](https://longbridge.com/zh-HK/news/279536547.md)
- [New Buy Rating for Kingboard Laminates Holdings (1888), the Technology Giant](https://longbridge.com/zh-HK/news/279535649.md)
- [Trump to hold news conference Monday prior to Kennedy Center board meeting](https://longbridge.com/zh-HK/news/279284985.md)
- [08:24 ETZentiva vydává Zprávu o udržitelnosti za rok 2025, čímž posiluje svůj závazek vůči lidem, partnerům a planetě.](https://longbridge.com/zh-HK/news/279431011.md)